132 related articles for article (PubMed ID: 28866246)
1. Radiofrequency Ablation for Renal Cancer in Von Hippel-Lindau Syndrome Patients: A Prospective Cohort Analysis.
Allasia M; Soria F; Battaglia A; Gazzera C; Calandri M; Caprino MP; Lucatello B; Velrti A; Maccario M; Pasini B; Bosio A; Gontero P; Destefanis P
Clin Genitourin Cancer; 2017 Aug; ():. PubMed ID: 28866246
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multiple synchronous misdiagnosed renal cell cancers in a young patient affected by a "de novo" Von Hippel-Lindau syndrome.
Allasia M; Battaglia A; Pasini B; Gazzera C; Calandri M; Bosio A; Gontero P; Destefanis P
Urologia; 2017 Feb; ():0. PubMed ID: 28256701
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes.
Park BK; Kim CK; Park SY; Shen SH
Acta Radiol; 2013 May; 54(4):418-27. PubMed ID: 23446745
[TBL] [Abstract][Full Text] [Related]
4. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
Wessendorf J; König A; Heers H; Mahnken AH
Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
[TBL] [Abstract][Full Text] [Related]
5. Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: A longitudinal observational study.
Chan VW; Lenton J; Smith J; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Lewington A; Kimuli M; Cartledge J; Wah TM
Eur J Surg Oncol; 2022 Mar; 48(3):672-679. PubMed ID: 34728141
[TBL] [Abstract][Full Text] [Related]
6. Invasive management of renal cell carcinoma in von Hippel-Lindau disease.
Carrion DM; Linares-Espinós E; Ríos González E; Bazán AA; Alvarez-Maestro M; Martinez-Pineiro L
Cent European J Urol; 2020; 73(2):167-172. PubMed ID: 32782836
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel-Lindau disease.
Chen J; Zheng L; Zhang W; Wang Z; Yu J; Liang P
Int J Hyperthermia; 2024; 41(1):2308079. PubMed ID: 38346873
[TBL] [Abstract][Full Text] [Related]
8. Safety and oncological outcome following radiofrequency ablation of small renal masses in a single center.
Bersang AB; Søndergaard Mosholt KS; Verner Jensen C; Germer U; Holm M; Røder MA
Scand J Urol; 2021 Jun; 55(3):203-208. PubMed ID: 33739218
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].
Nao T; Shimamoto T; Karashima T; Kamei M; Fukuhara H; Fukata S; Satake H; Ashida S; Yamasaki I; Kamata M; Inoue K; Yamanishi T; Ogawa Y; Ito S; Shuin T
Hinyokika Kiyo; 2014 Sep; 60(9):415-20. PubMed ID: 25293793
[TBL] [Abstract][Full Text] [Related]
10. Patterns of intervention for renal lesions in von Hippel-Lindau disease.
Matin SF; Ahrar K; Wood CG; Daniels M; Jonasch E
BJU Int; 2008 Sep; 102(8):940-5. PubMed ID: 18485044
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.
Ito K; Soga S; Seguchi K; Shinchi Y; Masunaga A; Tasaki S; Kuroda K; Sato A; Asakuma J; Horiguchi A; Shinmoto H; Kaji T; Asano T
Oncol Lett; 2017 Jul; 14(1):918-924. PubMed ID: 28693252
[TBL] [Abstract][Full Text] [Related]
12. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
14. Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma.
Cooper CJ; Teleb M; Dwivedi A; Rangel G; Sanchez LA; Laks S; Akle N; Nahleh Z
Rare Tumors; 2015 Feb; 7(1):5583. PubMed ID: 25918603
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
16. [Radiofrequency ablation for recurred renal cell carcinoma in the solitary kidney due to von Hippel-Lindau disease--indication and tip on how to prevent the thermal injury of the adjacent organs].
Anai H; Nagata T; Sato T; Minoshima K; Horie M; Yoshiya K; Uchida H; Kichikawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2303-5. PubMed ID: 21224555
[TBL] [Abstract][Full Text] [Related]
17. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel-Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma.
Kim WT; Ham WS; Ju HJ; Lee JS; Lee JS; Choi YD
J Korean Med Sci; 2009 Dec; 24(6):1145-9. PubMed ID: 19949673
[TBL] [Abstract][Full Text] [Related]
19. Iatrogenic ureteric stricture post image guided renal cryoablation in a patient with von hippel-lindau syndrome.
Ng H; Chan VW; Cartledge J; Kimuli M; Ralph C; Jagdev S; Vasudev N; Bhattarai S; Lenton J; Smith J; Wah TM
Radiol Case Rep; 2021 Aug; 16(8):2057. PubMed ID: 34158894
[TBL] [Abstract][Full Text] [Related]
20. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
